Liver Cancer, Adult Clinical Trials

10 recruiting

Liver Cancer, Adult Trials at a Glance

10 actively recruiting trials for liver cancer, adult are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 1 with 2 trials, with the heaviest enrollment activity in Ankara, Beijing, and Beijing. Lead sponsors running liver cancer, adult studies include University of California, San Diego, Eureka Therapeutics Inc., and Beijing Tsinghua Chang Gung Hospital.

Browse liver cancer, adult trials by phase

Treatments under study

About Liver Cancer, Adult Clinical Trials

Looking for clinical trials for Liver Cancer, Adult? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Liver Cancer, Adult trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Liver Cancer, Adult clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

Liver Cancer, Adult
University of California, San Diego80 enrolled3 locationsNCT05705219
Recruiting

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

Liver Cancer, Adult
Ankara University150 enrolled20 locationsNCT07345247
Recruiting

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

Liver CancerHepatocellular Carcinoma (HCC)Liver Cancer, Adult
University Hospital, Ghent80 enrolled1 locationNCT07315633
Recruiting
Early Phase 1

NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC

Liver Cancer, Adult
West China Hospital30 enrolled1 locationNCT07295262
Recruiting
Phase 1Phase 2

T-Cell Therapy (ECT204) in Adults With Advanced HCC

Hepatocellular CarcinomaMetastatic Liver CancerLiver Cancer, Adult+1 more
Eureka Therapeutics Inc.20 enrolled7 locationsNCT04864054
Recruiting
Not Applicable

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

Obesity and OverweightLiver Cancer, AdultMASH - Metabolic Dysfunction-Associated Steatohepatitis
University of California, San Diego50 enrolled1 locationNCT06824974
Recruiting

Digital Early Warning System for Acute Lung Injury in Liver Surgery

MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Acute Lung Injury(ALI)Liver Cirrhosis+4 more
Beijing Tsinghua Chang Gung Hospital4,000 enrolled1 locationNCT07070362
Recruiting

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting

Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma

Liver Cancer, Adult
IRCCS Azienda Ospedaliero-Universitaria di Bologna100 enrolled1 locationNCT06777628
Recruiting
Phase 1

Mts105 for Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)HCC - Hepatocellular CarcinomaLiver Cancer, Adult+1 more
Shen Lin14 enrolled1 locationNCT06689540